Literature DB >> 8079829

Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies.

N Bertazzolo1, L Punzi, M P Stefani, G Cesaro, M Pianon, B Finco, S Todesco.   

Abstract

High levels of many cytokines, including interleukin (IL)-1, IL-6 and IL-8, were found in various arthropathies suggesting that they play a role in the pathogenesis of disease, although their relationship with the type and activity of disease is still not clear. The synovial fluid (SF) of 24 patients with rheumatoid arthritis (RA), 19 with psoriatic arthritis (PA) and 33 with osteoarthritis (OA) was analyzed for IL-1 beta, IL-6 and IL-8. The highest concentration of the three cytokines was found in the SF of RA. IL-beta detectable levels (> or = 20 pg/ml) were observed in 8/24 (33.3%) patients with RA, in one patient with PA but in no patient with OA. IL-6 (mean +/- SD) (1610.37 +/- 1781.65 pg/ml) was higher in RA than in PA (672.47 +/- 867.40 pg/ml, p = 0.043) and OA (89.45 +/- 120.52 pg/ml, p = 0.0001). IL-8 (1042.72 +/- 698.64 pg/ml) was higher in RA than in PA (660.36 +/- 625.11 pg/ml, p = 0.03) and OA (89.9 +/- 45.88 pg/ml, p = 0.0001). A correlation between IL-1 beta, IL-6 and IL-8 was found in RA. In all patients a correlation between IL-6 and IL-8 levels was found; moreover, these two cytokines were associated with SF indices of inflammation, such as white blood cells (WBC) count and total protein (TP) concentration. Our findings suggest that these interrelationships play a role in the evolution of more severe erosive arthropathy such as RA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079829     DOI: 10.1007/bf01986402

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  6 in total

Review 1.  The role of cytokines and their inhibitors in arthritis.

Authors:  J M Dayer; H Fenner
Journal:  Baillieres Clin Rheumatol       Date:  1992-06

2.  Production of interleukin 8 by cultured synovial cells in response to interleukin 1 and tumor necrosis factor.

Authors:  K Hirota; T Akahoshi; H Endo; H Kondo; S Kashiwazaki
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

3.  Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity.

Authors:  R Madhok; A Crilly; J Watson; H A Capell
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

Review 4.  Interleukin-6: possible implications in human diseases.

Authors:  T Hirano; T Kishimoto
Journal:  Ric Clin Lab       Date:  1989 Jan-Mar

5.  Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis.

Authors:  M Field; C Chu; M Feldmann; R N Maini
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

6.  Production of neutrophil activating peptide-1 (NAP-1/IL-8) by blood and synovial fluid mononuclear cells from patients with arthritis.

Authors:  S Bas; T L Vischer; M Ceska; M Zsak; I Lindley; B Dewald; M Baggiolini; M Isak
Journal:  Clin Exp Rheumatol       Date:  1992 Mar-Apr       Impact factor: 4.473

  6 in total
  16 in total

1.  Different ELR (+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behçet's disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis.

Authors:  Hakan Erdem; Salih Pay; Muhittin Serdar; Ismail Simşek; Ayhan Dinç; Uğur Muşabak; Aysel Pekel; Mustafa Turan
Journal:  Rheumatol Int       Date:  2004-11-03       Impact factor: 2.631

2.  Interrelationship between synovial fluid interleukin (IL)-6, IL-1 beta and disease activity indices in rheumatoid arthritis.

Authors:  L Punzi; M Pianon; N Bertazzolo; B Finco; G Cesaro; S Todesco
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

3.  Regenerative Potential and Inflammation-Induced Secretion Profile of Human Adipose-Derived Stromal Vascular Cells Are Influenced by Donor Variability and Prior Breast Cancer Diagnosis.

Authors:  Adrienne M Parsons; Deborah M Ciombor; Paul Y Liu; Eric M Darling
Journal:  Stem Cell Rev Rep       Date:  2018-08       Impact factor: 5.739

Review 4.  Emerging drugs for osteoarthritis.

Authors:  Gloria L Matthews; David J Hunter
Journal:  Expert Opin Emerg Drugs       Date:  2011-05-04       Impact factor: 4.191

Review 5.  Engineering Closed-Loop, Autoregulatory Gene Circuits for Osteoarthritis Cell-Based Therapies.

Authors:  Rhima M Coleman
Journal:  Curr Rheumatol Rep       Date:  2022-04-11       Impact factor: 4.592

Review 6.  Breaking old paradigms: Th17 cells in autoimmune arthritis.

Authors:  Ariana Peck; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2009-04-28       Impact factor: 3.969

7.  Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients.

Authors:  Yeon-Ah Lee; Jung Yeon Kim; Seung-Jae Hong; Sang-Hoon Lee; Myung Chul Yoo; Kyoung Soo Kim; Hyung-In Yang
Journal:  Clin Rheumatol       Date:  2007-03-29       Impact factor: 2.980

8.  Does hyaluronan affect inflammatory cytokines in knee osteoarthritis?

Authors:  Melek Sezgin; Alev Cevikol Demirel; Cevriye Karaca; Ozgür Ortancil; Gül Bahar Ulkar; A Kanik; Aytül Cakçi
Journal:  Rheumatol Int       Date:  2004-03-04       Impact factor: 2.631

9.  Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen.

Authors:  P Sacerdote; M Carrabba; A Galante; R Pisati; B Manfredi; A E Panerai
Journal:  Inflamm Res       Date:  1995-11       Impact factor: 4.575

Review 10.  Human genome-wide expression analysis reorients the study of inflammatory mediators and biomechanics in osteoarthritis.

Authors:  J D Sandy; D D Chan; R L Trevino; M A Wimmer; A Plaas
Journal:  Osteoarthritis Cartilage       Date:  2015-11       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.